These final results, together with a previous report showing that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,2 guidance the idea of focusing on ACKR3 as a singular strategy to modulate the opioid technique, which could open up new therapeutic avenues for opio